ESAR treatment: Endograft + Heli-FX Endoanchor
DeviceESAR treatment: Endurant II or Endurant IIs endograft + Heli-FX Endoanchor
NCT Number: NCT04503395
The aim of this randomized study is to compare the safety and performance of EndoVascular Aneurysm Repair with ESAR using Endurant + Heli-FX™ EndoAnchor™ system and FEVAR using customizable grafts from Cook (Zenith Fenestrated Graft) and Terumo (Fenestrated Anaconda Graft) for the treatment of aortic aneurysms with short aortic neck (4 to 15mm).
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Hospital Ottakring, Institute for Vascular Surgery, Vienna, Austria
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
CT Angiographic Inclusion Criteria
Exclusion criteria
ESAR treatment: Endurant II or Endurant IIs endograft + Heli-FX Endoanchor
Cook Zenith Fenestrated Graft or the Terumo Fenestrated Anaconda Graft
Time frame: through 12 months post-procedure
Composite of technical success at index procedure, and freedom from type IA or type III endoleak, freedom from aneurysm related mortality (ARM), and freedom from secondary reinterventions through 12 months post index procedure.
Time frame: through 30 days post-procedure
Freedom from MAE through 30 days post index procedure. MAE defined as: All-Cause-Mortality, Bowel Ischemia, Myocardial Infraction, Procedural Blood Loss > 1000cc, Access related complications, permanent paraplegia and paraparesis at 30 days, disabling stroke, respiratory failure, or renal complications
Time frame: at index procedure
Total contrast volume (mL) at index procedure
Time frame: at index procedure
Total fluoroscopy time (minutes) at index procedure
Time frame: at index procedure
Time frame: at index procedure
Adequate penetration of EndoAnchor implants as assessed by the Core Lab
Time frame: through 30 days post-procedure
Time frame: through 1,12,24 and 36-months post-op
Visceral artery patency or occlusion at 1, 12, 24 and 36 months follow-up
Time frame: through 1,12,24 and 36-months post-op
Freedom from type Ia and III endoleaks at 1, 12, 24 and 36 months follow-up
Time frame: through 1,12,24 and 36-months post-op
Freedom from aneurysm related secondary reinterventions at 1, 12, 24 and 36 months follow-up
Time frame: through 1,12,24 and 36-months post-op
Freedom from aneurysm related mortality at 1, 12, 24 and 36 months follow-up
Time frame: through 12,24 and 36-months post-op
Freedom from stent graft migration (>10mm change from 1-month follow-up imaging) at 12, 24 and 36 months follow-up
Time frame: through 12,24 and 36-months post-op
Sac dynamics (>5mm change from 1-month follow-up imaging): increase, stable, decrease at 12, 24, and 36 months follow-up
Time frame: through 1,12,24 and 36-months post-op
Freedom from conversion to open repair at 1, 12, 24 and 36 months follow-up
Time frame: through 1,12,24 and 36-months post-op
Freedom from AAA rupture at 1, 12, 24 and 36 months follow-up
Time frame: through 1 and 12 months post-op
Overall SCI rate, include transient events at 1 and 12 months follow-up
Time frame: at 1-, 12-, 24- and 36-months follow-up
reinterventions for Type IAa endoleak, migration of the proximal stent graft, and progression of disease in the infrarenal aortic neck; progression of disease is defined as enlargement of the infrarenal aortic neck compared to the first postprocedural CT scan, as measured by either diameter, surface and/or volume.
Contact information is provided by the study sponsor or research team.
FCRE (Foundation for Cardiovascular Research and Education)
Other
Physician Initiated Trial Investigating ESAR (EVAR Plus Heli-FX EndoAnchors) and FEVAR for the Treatment of Aortic Aneurysms With Short Infrarenal Aortic Neck
Acronym: SOCRATES
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07005141
Aneurysm, Aortic Aneurysm
Florianópolis, Santa Catarina, Brazil
View Trial DetailsNCT05484115
Aneurysm, Aortic Aneurysm
Washington, Arkansas, United States
View Trial DetailsNCT04875429
Aneurysm, Aortic Aneurysm
Birmingham, Alabama, United States
View Trial DetailsNCT03446287
Aneurysm, Aortic Aneurysm
Rochester, Minnesota, United States
View Trial Details